Innospec Inc. (IOSP)
IOSP trades on Nasdaq in Industrials, Major Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1054905/000119312526056502/0001193125-26-056502-index.htm. Net income: SEC 10-K (us-gaap:ProfitLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | IOSP on Nasdaq |
| Sector | Industrials |
| Industry | Major Chemicals |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001054905 |
| SEC industry code | Chemicals & Allied Products |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.8B |
| Net income | $116.6M |
| Operating income | $129.5M |
| Net margin | 6.6% |
| Operating margin | 7.3% |
| Revenue growth | -3.7% |
| Cash | $292.5M |
| Total assets | $1.8B |
| P/E (computed) | 16.7× |
| P/S (computed) | 1.1× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-04 |
| Cash and burn | $251.9M cash; operating cash flow $25.6M a quarter. | Report 2026-09-30 |
| Shares outstanding | 24,631,595 (2026-10-31); 24,777,582 a year earlier; 24,865,799 three years earlier. | Cover page 2026-10-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Manchester, United Kingdom | PCAOB Form AP 2026-03-25 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $25K, sold $636K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $473.6M | $31.8M | $17.4M | $251.9M | No debt tags | $1.9B | 10-Q 2026-11-04 |
| Q2 2026 2026-06-30 | $491.4M | $30.8M | $7.2M | $250.2M | No debt tags | $1.8B | 10-Q 2026-08-05 |
| Q1 2026 2026-03-31 | $453.2M | $30.4M | $17.6M | $289.1M | No debt tags | $1.8B | 10-Q 2026-05-08 |
| Q4 2025 2025-12-31 | $455.6M | $46.4M | $60.4M | $292.5M | No debt tags | $1.8B | 10-K 2026-02-18 |
| Q3 2025 2025-09-30 | $441.9M | $12.9M | $39.1M | $270.8M | No debt tags | $1.8B | 10-Q 2026-11-04 |
| Q2 2025 2025-06-30 | $439.7M | $23.5M | $10.5M | $266.6M | No debt tags | $1.8B | 10-Q 2026-08-05 |
| Q1 2025 2025-03-31 | $440.8M | $32.8M | $28.3M | $299.8M | No debt tags | $1.8B | 10-Q 2026-05-08 |
| Q4 2024 2024-12-31 | $466.8M | -$70.4M | $25.7M | $289.2M | No debt tags | $1.8B | 10-K 2026-02-18 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-02-18 |
| Latest quarterly / interim | 10-Q | 2026-11-04 |
| Latest current report | 8-K | 2026-11-03 |
| Latest proxy | DEFA14A | 2026-03-26 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.8% |
| 1 month | -17.5% |
| 3 months | -14.4% |
| Year to date | +5.0% |
| 1 year | +7.5% |
| From 52-week high | -20.7% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Major Chemicals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OLN | Olin Corporation | $16.89 | -3.26% | $1.9B |
| MTX | Minerals Technologies Inc. | $60.57 | -1.24% | $1.9B |
| CC | Chemours Company (The) | $12.48 | -5.47% | $1.9B |
| NGVT | Ingevity Corporation Common Stock | $60.02 | -2.75% | $2.0B |
| ROG | Rogers Corporation | $123.46 | -1.73% | $2.2B |
| HUN | Huntsman Corporation | $9.30 | -2.41% | $1.6B |
| STDN | Standard Nuclear Inc. | $9.33 | -11.56% | $1.5B |
| KWR | Quaker Houghton | $152.07 | -2.16% | $2.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier